Results of Immediate Postpartum Long Acting Reversible Contraception Provision After Expanded Reimbursement Policy Implementation at an Academic Medical Institution

Matern Child Health J. 2023 Nov;27(11):1914-1919. doi: 10.1007/s10995-023-03738-w. Epub 2023 Jun 8.

Abstract

Introduction: Immediate postpartum (IPP) Long Acting Reversible Contraception (LARC) is effective in reducing short birth spacing, which is highest among minoritized and younger women with lower socioeconomic status. The structural barrier of cost for pregnant people who desire IPP LARC insertion was alleviated in 2016 when New York State provided statewide reimbursement for Medicaid recipients.

Methods: Analyses of existing electronic medical records (EMR) were conducted on women who received IPP LARC between 3/2/17 and 9/2/19 at two hospitals after a term delivery, defined as gestational age 37 0/7 weeks or greater. Descriptive and bivariate statistics, including chi-square tests and Fischer's exact tests, based on cell sizes, were calculated using SAS (version9.4).

Results: Prior to the study period, IPP LARC was not placed in these hospitals. After reimbursement policy changes, electronic medical record data identified 501 women with full term delivery and IPP LARC placed, of which the majority were single (82.8%), Black (49.1%), and had public insurance (Medicaid and Medicaid Managed Care) (79.2%).

Discussion: Removing structural economic barriers for people using public insurance may increase health equity in contraceptive access and choice.

Keywords: Access to Health Services; Contraceptive Access; Equity, Health; Long Acting Reversible Contraception; Reimbursement, Health Insurance.

MeSH terms

  • Contraception
  • Female
  • Health Policy
  • Health Services Accessibility
  • Humans
  • Long-Acting Reversible Contraception*
  • Medicaid
  • Postpartum Period
  • Pregnancy
  • United States